Zhang, Liyong
Li, Zhihong
Liu, Yehai
Xu, Shuping
Tandon, Manuj
Appelboom, Brittany
LaValle, Courtney R.
Chiosea, Simion I.
Wang, Lin
Sen, Malabika
Lui, Vivian W. Y.
Grandis, Jennifer R.
Wang, Q. Jane
Funding for this research was provided by:
National Institutes of Health (R01CA129127, R01CA142580, SPORE in Head and Neck Cancer (P50CA097190) pilot fund, P50CA097190)
U.S. Department of Defense (PC150190)
Article History
Received: 7 March 2018
Accepted: 17 October 2018
First Online: 12 November 2018
Ethics approval and consent to participate
: Human tissues used in this study are de-identified and publicly available. They are thus exempt from the requirement of IRB approval (Exempt Category 4). Cell lines were from ATCC, and a few of them were from Dr. Grandis. No ethics approval is needed for their use.Institutional Animal Care and Use Committee: All experimental procedures involving animals were approved by the University of Pittsburgh.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.